Finch Therapeutics Group, Inc. (FNCHQ)
OTCMKTS · Delayed Price · Currency is USD
10.50
+0.40 (3.96%)
At close: Jul 2, 2026
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $16.86 million as of July 7, 2026. Its market cap has decreased by -31.69% in one year.
Market Cap
16.86M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$10.50
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 16.86M, a decrease of -98.32%. That is a compound annual growth rate of -53.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 16.86M | -22.15% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIVO Bioscience | 21.80M |
| BetterLife Pharma | 21.21M |
| Oncotelic Therapeutics | 18.62M |
| Zenith Capital | 15.97M |
| Anebulo Pharmaceuticals | 15.01M |
| Galera Therapeutics | 14.28M |
| Zeo ScientifiX | 14.19M |
| Inhibitor Therapeutics | 13.64M |